FoxP3-Positive T-Regulatory Cells in Lymph Nodes with Mycosis Fungoides and Sézary Syndrome

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td align="left">Antibody</td><td align="center">Manufacturer</td><td align="center">Dilution</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td align="left">CD3</td><td align="center">Dako, Carpinteria, CA</td><td align="center">1 : 100</td></tr><tr><td align="left">CD4</td><td align="center">Dako, Carpinteria, CA</td><td align="center">1 : 10</td></tr><tr><td align="left">CD30</td><td align="center">Dako, Carpinteria, CA</td><td align="center">1 : 50</td></tr><tr><td align="left">Foxp3 (236A/E7)</td><td align="center">Abcam, Cambridge, MA</td><td align="center">1 : 25</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Antibodies and dilutions used in the study.

Lymphoma

tab2

Table 2

Table 2: FoxP3-Positive T-Regulatory Cells in Lymph Nodes with Mycosis Fungoides and Sézary Syndrome 